SAB Biotherapeutics Novel DiversitAb Platform Proven To Develop Anti-idiotype Antibodies To Help Treat Autoimmune Diseases
SAB Biotherapeutics (NASDAQ:SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for
SAB Biotherapeutics Announces $7.9M Private Placement Of Common Stock At $1.08/Share
SAB Biotherapeutics (NASDAQ:SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for
Benzinga’s Top Ratings Upgrades, Downgrades For November 29, 2022
Upgrades According to Wedbush, the prior rating for The GEO Group Inc (NYSE:GEO) was changed from Neutral to…
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.